CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Common Stock Restricted stock units	Additional Paid-in Capital	Retained Earnings	Treasury Stock	Accumulated Other Comprehensive (Loss)/Income	Non-controlling interest
Balance, beginning of period (in shares) at Dec. 31, 2020		56,108
Balance, beginning of period at Dec. 31, 2020	$ 1,983,018	$ 56		$ 660,771	$ 1,347,880	$ (177)	$ (25,512)	$ 0
Treasury stock, beginning of period (in shares) at Dec. 31, 2020						20
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock units vested (in shares)			311
Equity withheld for employee taxes (in shares)		(106)
Equity withheld for employee taxes	(45,070)			(45,070)
Stock-based compensation expense	69,899			69,899
Exercise of stock options (in shares)		536
Exercise of stock options	26,313	$ 1		26,312
Noncontrolling interests acquired in business combination	10,469							10,469
Purchase of subsidiary shares from noncontrolling interest	(1,749)							(1,749)
Other comprehensive income	(28,695)						(28,695)
Net income	481,652				481,652
Balance, end of period (in shares) at Dec. 31, 2021		56,849
Balance, end of period at Dec. 31, 2021	2,495,837	$ 57		711,912	1,829,532	$ (177)	(54,207)	8,720
Treasury stock, end of period (in shares) at Dec. 31, 2021						20
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock units vested (in shares)			252
Equity withheld for employee taxes (in shares)		(83)
Equity withheld for employee taxes	(23,650)			(23,650)
Stock-based compensation expense	107,513			107,513
Exercise of stock options (in shares)		511
Exercise of stock options	21,851	$ 1		21,850
Purchase of subsidiary shares from noncontrolling interest	(7,266)			49				(7,315)
Other comprehensive income	(41,114)						(41,114)
Net income	419,416				419,416
Stock issued in connection with Other 2021 acquisitions (Note 3) (in shares)		6				(6)
Stock issued in connection with Other 2021 acquisitions (Note 3)	2,000			1,941		$ 59
Issuance of common stock from employee stock purchase plan (in shares)		120
Issuance of common stock from employee stock purchase plan	28,350			28,350
Contributions to consolidated subsidiary from noncontrolling interest	$ 73							73
Balance, end of period (in shares) at Dec. 31, 2022	57,655	57,655
Balance, end of period at Dec. 31, 2022	$ 3,003,010	$ 58		847,965	2,248,948	$ (118)	(95,321)	1,478
Treasury stock, end of period (in shares) at Dec. 31, 2022						14
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock units vested (in shares)			336
Equity withheld for employee taxes (in shares)		(103)
Equity withheld for employee taxes	(29,301)			(29,301)
Stock-based compensation expense	135,500			135,500
Exercise of stock options (in shares)		398
Exercise of stock options	15,513	$ 0		15,513
Purchase of subsidiary shares from noncontrolling interest	(1,453)			(48)				(1,405)
Other comprehensive income	56,281						56,281
Net income	417,083				417,083
Stock issued in connection with Other 2021 acquisitions (Note 3) (in shares)		14				(14)
Stock issued in connection with Other 2021 acquisitions (Note 3)	3,000			2,882		$ 118
Issuance of common stock from employee stock purchase plan (in shares)		173
Issuance of common stock from employee stock purchase plan	36,255			36,255
Contributions to consolidated subsidiary from noncontrolling interest	506							506
Repurchase of common stock (in shares)		(686)
Repurchase of common stock	$ (164,924)				(164,924)
Balance, end of period (in shares) at Dec. 31, 2023	57,787	57,787
Balance, end of period at Dec. 31, 2023	$ 3,471,470	$ 58		$ 1,008,766	$ 2,501,107	$ 0	$ (39,040)	$ 579
Treasury stock, end of period (in shares) at Dec. 31, 2023						0